Axon Enterprise vs. UiPath: Which Industrials Stock Is a Better Buy for 2027?

Source The Motley Fool

Key Points

  • Axon Enterprise maintains a dominant position in the law enforcement technology market with a robust ecosystem of hardware and cloud software.

  • UiPath is demonstrating significant progress in enterprise automation and profitability by integrating artificial intelligence into its workflow platform.

  • Which of these technology leaders is the more compelling choice for your long-term portfolio?

  • Motley Fool Issues Rare "Total Conviction" Buy Alert ›

Choosing between a leader in public safety and a titan of enterprise automation involves weighing high-growth hardware against AI-integrated software. Is Axon Enterprise (NASDAQ:AXON) or UiPath Inc.(NYSE:PATH) the better long-term play?

Axon dominates the law enforcement technology space with its integrated ecosystem of body cameras and cloud software. UiPath helps large organizations automate repetitive tasks using artificial intelligence and business orchestration. While they serve different markets, both leverage software-as-a-service models to drive recurring revenue, making them interesting candidates for investors looking toward 2027.

The case for Axon Enterprise

Axon Enterprise sells Taser devices, body cameras, and cloud evidence management software primarily to law enforcement and first responders. It also serves fire departments, emergency medical services, and commercial enterprises. No single customer accounted for more than 10% of total net sales in its latest annual report, indicating a well-distributed client base.

In the 12 months ended Sept. 30, 2026, revenue reached about $3.4 billion, reflecting a revenue growth of roughly 33.6%. During this same period, the company reported net income of around $258.5 million. This growth demonstrates strong demand for its digital evidence platform among defense stocks and public safety agencies.

As of its December 2025 balance sheet, the debt-to-equity ratio was approximately 0.6x, which measures total debt against shareholder equity. The current ratio, which gauges the ability to cover short-term liabilities with short-term assets, was roughly 2.5x. In the fiscal year ended Dec. 31, 2025, free cash flow was about $75.1 million; note that stock-based compensation represented roughly 300% of operating cash flow, meaning reported cash generation is heavily inflated by this non-cash add-back.

The case for UiPath

UiPath provides an automation platform that combines AI and orchestration to streamline enterprise workflows. It serves 357 customers with over $1 million in annual recurring revenue, focusing on large organizations and government agencies. The company relies heavily on channel partners and strategic alliances to reach global markets and support complex implementations.

In the 12 months ended July 31, 2026, revenue reached about $1.7 billion, representing revenue growth of approximately 15%. Net income for this period was around $361.9 million. This performance shows a successful pivot toward higher profitability as the company matures and expands its presence in the tech stocks sector.

As of its January 2026 balance sheet, the debt-to-equity ratio was 0.0x, indicating a debt-free position where total debt is zero. The current ratio was roughly 2.5x. In the fiscal year ended Jan. 31, 2026, free cash flow was about $352.2 million. Note that stock-based compensation represented roughly 78.3% of operating cash flow, which inflates reported cash generation since stock-based compensation is a non-cash expense added back in the cash flow statement.

Risk profile comparison

Axon Enterprise faces risks from revenue concentration within law enforcement agencies and their continued acceptance of new products. The company must also navigate legal and reputation risks related to product liability claims or wrongful death lawsuits. Additionally, it faces competition from firms like Motorola Solutions (NYSE:MSI) and Wrap Technologies (NASDAQ:WRAP) in the sensor and evidence management markets.

UiPath is highly dependent on the continued market acceptance of its platform amid intense competition from software giants like Microsoft Corp. (NASDAQ:MSFT), Salesforce.com Inc. (NYSE:CRM), and Oracle Corp. (NYSE:ORCL). It also faces operational risks from its rapid growth strategy and the integration of acquisitions. Significant customer concentration risk exists, as a large portion of revenue comes from a limited number of major enterprise accounts.

Valuation comparison

UiPath appears more affordable on both earnings and sales metrics, while Axon carries a significant premium that likely reflects its faster top-line growth.

MetricAxon EnterpriseUiPath
Forward P/E42.6x16.7x
P/S ratio7.3x4.0x

Valuation metrics include those sourced from Financial Modeling Prep (FMP) and may differ from those of other data providers.

Which stock would I buy for 2027?

UiPath says that in the age of AI, its platform is about orchestration of enterprisewide software and systems to enable companies to find the efficiencies that AI promises. The company says it provides guardrails around AI and also works to ensure exactness--the idea being that even if AI is accurate 99.9% of the time, businesses like banks and medical providers need 100% accuracy. UiPath management says many businesses are deploying AI agents, but few have the connective tissue to link these single-task agents to the larger enterprise and to the multiple other software platforms a company has deployed. UiPath says its software provides all that in a vendor-agnostic manner.

AI is becoming a dominant theme in UiPath's business, with 18 of its 20 largest deals in its most recently reported quarter involving AI. The business has raised its annual recurring revenue to more than $1.9 billion in its second quarter of fiscal 2027, up 13% year over year. Revenue in the quarter rose 13% to $410 million. For the full-year fiscal 2027, Wall Street analysts project revenue to rise 11% to $1.79 billion. Net income is expected to drop 30% to $200 million, though free cash flow is set to rise about 16% to $425 million, according to consensus estimates.

Turning to Axon, it has a positive outlook for growth as law enforcement is increasingly equipped with Tasers and the public is becoming increasingly demanding that agents wear body cameras. Its cloud-based evidence control system is also an increasingly sought-after service for law enforcement organization.

Expansion into Europe and Canada should also help, as should a focus on producing personal consumer-protection devices. In particular, all the data and video created by Axon customers have to be managed, and the company is seeing strong demand for its AI-based management systems from customers who find many of the services create efficiencies within their operations.

In fiscal 2026, sales are expected to grow well, up about a third to $3.7 billion, with net income of around $290 million and free cash flow of $425 million, well over 2025's levels. In 2027, consensus estimates project adding another $1 billion in revenue, with expanding net income and free cash flow as well.

Axon comes at a premium, as seen through its P/E and P/S ratios, but the company is delivering exceptional sales growth and improving margins. UiPath is growing more slowly, and its more value-like valuation in the market reflects concern that what AI can provide to UiPath's business could eventually erode its business by increasing competition. For 2027, go with Axon and its exceptional top-line growth.

Missed AI’s "Act 1"? Act 2 Could Be 14x Bigger

Most investors think they missed the AI boat because they didn't buy Nvidia in 2005.

But according to our analysts, we’re only at the end of "Act 1"—the R&D phase. "Act 2" is the global rollout, a massive technology build-out that Google’s CEO says could be more profound than fire or electricity.

While everyone watches the chip designers, one "backbone" company provides the critical technology that Nvidia and AMD literally cannot function without. We’ve detailed this under-the-radar player in our new AI Playbook.

Continue »

Brendan Coffey has no position in any of the stocks mentioned. The Motley Fool has positions in and recommends Axon Enterprise, Microsoft, Oracle, Salesforce, and UiPath. The Motley Fool has a disclosure policy.

Disclaimer: For information purposes only. Past performance is not indicative of future results.
placeholder
Gold Price Forecast: XAU/USD regains ground below $3,700, outlook remains fragileGold price (XAU/USD) attracts some bids after hitting a fresh yearly low at $3,693.50 on Thursday. In the European trade, the Gold price is 0.42% higher to near $3,740.
Author  FXStreet
8 hours ago
Gold price (XAU/USD) attracts some bids after hitting a fresh yearly low at $3,693.50 on Thursday. In the European trade, the Gold price is 0.42% higher to near $3,740.
placeholder
Gold Price Analysis Today | Forex Gold Analysis | XAU/USD Analysis - November 19, 2026Get the latest gold price analysis, forex gold insights, and XAU/USD analysis for November 19, 2026. Read on for the details.
Author  Mitrade
13 hours ago
Get the latest gold price analysis, forex gold insights, and XAU/USD analysis for November 19, 2026. Read on for the details.
placeholder
Australian Dollar falls below 0.6700 as Unemployment Rate jumps to the highest level in five yearsThe AUD/USD pair tumbles to its lowest since January around 0.6695 during the early Asian session on Thursday. The Australian Dollar (AUD) faces some selling pressure against the US Dollar (USD) following weaker-than-expected Australian employment data.
Author  FXStreet
15 hours ago
The AUD/USD pair tumbles to its lowest since January around 0.6695 during the early Asian session on Thursday. The Australian Dollar (AUD) faces some selling pressure against the US Dollar (USD) following weaker-than-expected Australian employment data.
placeholder
US Dollar Index Price Forecast: DXY could target 104.00 as bulls await FOMC MinutesThe US Dollar Index (DXY), which tracks the Greenback against a basket of currencies, regains positive traction following the previous day's brief pause, retesting its highest level since April 2025 during the first half of the European session on Wednesday.
Author  FXStreet
Yesterday 10: 14
The US Dollar Index (DXY), which tracks the Greenback against a basket of currencies, regains positive traction following the previous day's brief pause, retesting its highest level since April 2025 during the first half of the European session on Wednesday.
placeholder
Gold Hits Near 1.5-Year Low Below $3,800 as Bears Threaten Drop to $3,500Gold prices broke below the $3,800 threshold to hit a new low since September 2025, warranting heightened vigilance over downside risk toward $3,500.On November 18, international spot gol
Author  TradingKey
Yesterday 08: 35
Gold prices broke below the $3,800 threshold to hit a new low since September 2025, warranting heightened vigilance over downside risk toward $3,500.On November 18, international spot gol
goTop
quote